The intrinsic and extrinsic pathways merge through the activation of. For instance, the presence of cancer stem cells with robust intrinsic drug resistance capabilities reduces the chemotherapy efficacy. Cancer cells express multiple drug resistance mdr by initially developing resistance to a single anticancer drug, and slowly to various anticancer agents that are structurally similar but possess different mechanisms of action. The establishment of chemoresistant cancer cell lines might be one of the useful model systems to study molecular mechanisms leading to cancer drug resistance 17. After drug challenge, the cells were incubated at 378c for 10 days until. However, most current research is focused on tumorspecific factors and. Novel compounds line up to combat drug resistance in cancer cells.
Tumor heterogeneity may also contribute to resistance, where small subpopulations. Mechanisms of drug resistance that increase drug efflux from cancer cells it came as something of a surprise that the major mechanism of multidrug resistance in cultured cancer cells was the expression of an energydependent drug ef. Drug resistance and the role of combination chemotherapy. This is a very serious problem that may lead to recurrence of disease or even death. Donnenberg, phd the failure to eradicate most cancers may be as fundamental as a misidentification of the target. Lung cancer, resistance to gemcitabine and cisplatin, transition phenotypes. Aug 23, 2016 the two publications report on the engineering of two separate nanoparticles that test different strategies for achieving chemosensitization of cancer cells. Overcoming multidrug resistance in cancer stem cells. Although, quite often multidrug resistance is associated to the overexpression of the membrane efflux pump pglycoprotein, other mechanisms may account for the observed resistance of dreng2 and ddreng2 cells. Researchers identified an existing drug that reverses stem celllike properties of tumors, resensitizing them to drug. Apr 21, 2014 most drugs used to treat lung, breast and pancreatic cancers also promote drug resistance and ultimately spur tumor growth. Many drugs have been designed or discovered and used to kill cancer cells. Our current therapies succeed at eliminating bulky disease and rapidly proliferating cells but often miss a tumor.
Multiple drug resistance mdr, multidrug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to at least one antimicrobial drug in three or more antimicrobial categories. One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. Various mechanisms that have been proposed include enhanced intracellular concentration of the drug by endocytosis, 1. Pavello central, 5a planta, lr 5101 cfeixa llarga sn, e 08907. Multidrug resistance in cancer chemotherapy springerlink.
Altered metabolic pathways help cancer cells to proliferate at a rate higher than normal, adapt to nutrient limited conditions, and develop drug resistance phenotypes. The cells were treated with various concentrations of cisplatin for 12 hours, and then the drug was washed off with pbs. Chao the efficacy of cancer chemotherapy is often affected by the emergence of. Nanodrug formed by coassembly of dual anticancer drugs. Overcoming drug resistance by enhancing apoptosis of tumor cells volume. Chemotherapy resistance can arise due to several host or tumorrelated factors. Cancer stem cells linked to drug resistance sciencedaily. The field is complicated due to the wide array of pathways and mechanisms involved. Drug transporters in stem cells stem cells have many properties that separate them from mature, differentiated cells. Cancer cell article repression of stressinduced line1 expression protects cancer cell subpopulations from lethal drug exposure gulfem dilek guler,1,9 charles albert tindell,1,9 robert pitti,1 catherine wilson,1 katrina nichols,2 tommy kaiwai cheung,2 hyojin kim,1 matthew wongchenko,4 yibing yan,4 benjamin haley,5 trinna cuellar,5 joshua webster,6 navneet alag, 1ganapati hegde,1 erica.
Drug resistance is a common cause of treatment failure in cancer. Cancer stem cells and multiple drug resistance in breast cancer article pdf available in science and culture 8034. Resistance mechanism in adapted cells to cancer drugs. Endoplasmic reticulum stress signaling and chemotherapy. Resistance to chemotherapy is the single most important reason for treatment failure in cancer patients. Twoinone punch knocks out drug resistant cancer cells. Novel compounds line up to combat drug resistance in. The effects of alkaloids a19 on cell proliferation ic50 and drug resistance far in mdr cells. Categories of mechanisms that can enable or promote direct or indirect drug resistance in human cancer cells. The two publications report on the engineering of two separate nanoparticles that test different strategies for achieving chemosensitization of cancer cells. Drug resistance of cancer cells crucially affected by. It is thought that the probability of developing resistance to any one drug is reduced in this way 3. Furthermore, challenges and complexities regarding toxicity when combining these.
Most drugs used to treat lung, breast and pancreatic cancers also promote drugresistance and ultimately spur tumor growth. Researchers at the university of california, san diego school of medicine have discovered a biomarker called cd61 on the surface of drugresistant tumors that appears responsible for inducing tumor metastasis by enhancing the. Mathematics and drug resistance lavi, gottesman, levy. Hgf increases cisplatin resistance via downregulation of. Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. In the traditional view, cancer cells that survived during chemotherapy and acquired drug resistance gave rise to a population of drug resistant cancer cells. However, most current research is focused on tumorspecific factors and specifically genes that handle expression of. Resistance to cancer chemotherapy is a common phenomenon especially in metastatic breast cancer mbc, a setting in which patients typically have had exposure to multiple lines of prior therapy. Sirt5 facilitates cancer cell growth and drug resistance in. Although these drugs show remarkable effects during initial treatment, a large majority of. Overexpression of tyms in cancer cell lines increases the resistance of the cells to 5fu. Drug resistance and combating drug resistance in cancer. Cancer stem cells linked to drug resistance eurekalert.
However, most of the published scientific research papers poorly explained resistance induction methods in details 18, 19. The subsequent development of drug resistance can result in rapid disease progression during or shortly after completion of treatment. Two typical colorectal cancer cells, hct116 and lovo, were cultured with the. The effects of hydantoin derivatives on cell proliferation ic50 and drug resistance far in mdr cells. Overcoming cancer drug resistance has become a priority in the treatment of many types of cancer with drug resistant cells becoming harder to kill even with the arrival of new cytotoxic drugs. Novel compounds line up to combat drug resistance in cancer.
Two typical colorectal cancer cells, hct116 and lovo, were. Drug resistance is a serious impediment to the treatment of cancer. Mlejnek p, dolezel p, ruzickova e 2017 drug resistance of cancer cells is crucially affected by expression levels of abctransporters. Drug resistance in colorectal cancer cell lines is. Drug resistance has been studied in cancer cells grown. Apr 20, 2014 cancer stem cells linked to drug resistance by university of california san diego when lung cancer cells become drug resistant, tumor cells return as shown in brown. Mechanisms of chemotherapeutic drug resistance in cancer. Cancer stem cells and chemotherapeutic drug resistance the cancer stem cell hypothesis states that the cancer initiating cell is a transformed tissue stem cell, which is spared along with its normal tissue stem cell counter parts with very subtle differences. Pdf cancers have the ability to develop resistance to traditional therapies, and the. If the molecular basis of drug resistance could be understood, new types of treatment might be developed to cure these drugresistant cancers. Sirt5 facilitates cancer cell growth and drug resistance.
Furthermore, we find that sirt5 knockdown makes lung cancer cells more sensitive to drug cisdiamminedichloroplatinum cddp, 5fluorouracil 5fu or bleomycin treatment in vitro and in vivo. In some cases, cancers can evolve resistance to multiple drugs, called multiple drug resistance. In the traditional view, cancer cells that survived during chemotherapy and acquired drug resistance gave rise to a population of drugresistant cancer cells. One feature common among drug resistant and metastatic tumor cells is an increased resistance to apoptosisthe ability of cancer cells not only to grow and survive successfully in the stressful. Drug resistance in colorectal cancer cell lines is partially. Drug resistance in cancer cells kapil mehta springer. Since the vast majority of patients dying of cancer will have had anticancer therapy, both c.
Cancer stem cells linked to drug resistance 20 april 2014 when lung cancer cells become drug resistant, tumor cells return as shown in brown. Nanodrug formed by coassembly of dual anticancer drugs to. Drug resistance and cancer stem cells estudo geral. Drug resistance in cancer is a wellknown phenomenon that results when cancer becomes. And the role of selected single nucleotide polymorphisms in cancer ph. Cancer cells can acquire resistance to chemotherapy by a range of mechanisms, including the mutation or overexpression of the drug target, inactivation of the drug, or elimination of the drug from. Using drugs in combination seem a functioning strategy against drug resistance development.
This assay measures both replicating and static cells. Generation of cisplatinresistant ovarian cancer cell lines. The geneticnongenetic duality of drug resistance in cancer. The role of autophagy and apoptosis in the drug resistance of cancer. These transporters serve as the guardians of the stem cell population in the body. Combining inhibition of csf1r with inhibition of igf1 receptor or pi3k signaling has. Cancer drug resistance continues to be a major impediment in medical oncology.
Lung cancer is generally diagnosed too late to be operable, and consequently, chemotherapy provides the main treatment option for most lung cancer patients. Nov 04, 2009 cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the resistance of neoplastic cancerous cells, or the ability of cancer cells to survive and grow despite anti cancer therapies. Pdf cancer stem cells and multiple drug resistance in. Drug combinations to overcome treatment resistance. Cell cyclemediated drug resistance clinical cancer research. The mechanism of drug resistance for ovarian and breast cancer cells have been studied by the research team from the peoples friendship university of russia rudn university.
The center of the particle is loaded with the anticancer drug doxorubicin. Role of protein kinase ck2 in antitumor drug resistance. Cancer chemotherapy resistance mdr is the innate andor acquired ability of cancer cells to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in cancer therapy. The paradigm that drug resistance originates in the stemcell phenotype might stimulate new strategies for the development of anticancer therapies. Ck2 is an antiapoptotic kinase, which sustains cell survival by several mechanisms see above. So far, this issue has been discussed based on the mechanisms by which cancer cells become resistant, such as drug inactivation, alterations in cellular targets, suppression of drug. Far from being a phenomenon limited to the laboratory, multidrug resistance has been identified in a wide variety of newly diagnosed and recurrent. The concept of combining chemotherapeutic agents to increase cytotoxic efficacy has evolved greatly over the past several years. Overcoming drug resistance in cancer chemotherapy by using nms as delivery systems is a very hot area of research in this century. A priority in solving the problem of drug resistance is to understand the molecular mechanism of how a drug induces the resistance response within cells.
New molecules kill multidrug resistant cancer cells. Aguilar, in nanomaterials for medical applications, 20. Drug resistance in cancer an overview sciencedirect topics. Cancer cells acquire resistance to anticancer drugs. If the molecular basis of drug resistance could be understood, new types of treatment might be developed to cure these drug resistant cancers. Department of medical microbiology and immunobiology faculty of medicine university of szeged szeged 2012. The principle mechanism of protection of stem cells is through the expression of atpbinding cassette abc transporters. Antimicrobial categories are classifications of antimicrobial agents based on their mode of action and specific to target organisms. Pepita gimenezbonafe, avelina tortosa and ricardo pereztomas affiliation.
Using clinical drug resistance to kill cancer cells. Interaction between selected hydantoin derivatives and doxorubicin in mdr cells. Overcoming drug resistance by enhancing apoptosis of tumor. Aug 28, 2017 for instance, the presence of cancer stem cells with robust intrinsic drug resistance capabilities reduces the chemotherapy efficacy. The center of the particle is loaded with the anti cancer drug doxorubicin. Hgf increases cisplatin resistance via downregulation of aif. To date, at least 12 human abctransporters have been associated with drug resistance and drug transport in cancer cells 14. At least 4 of them, mdr1pgp, mrp1, mrp2 and bcrp, can be expressed. One of the most studied mechanisms of cancer drug resistance involves reducing drug accumulation by enhancing efflux. In addition to its function in protecting cells from the cytotoxic effect of antitumor drugs, its role has been also specifically described in the background of drug resistance, either in processes directly responsible for resistance, such. The combination of hcpt and dox exhibited a synergistic e. One way cancer cells accomplish this is by catching the intruding drug and throwing it out of the cell before it can act. This section is intended to introduce some of the main ways in which cancer cells can resist treatments.
Members of the atpbinding cassette abc transporter family proteins enable this efflux and are important, wellstudied regulators at the plasma membranes of healthy cells. Furthermore, drug resistance of lung cancer to chemotherapeutic drugs is one of the important causes of the failure of chemotherapy 4,5. Far from being a phenomenon limited to the laboratory, multidrug resistance has been identified in a wide. Apr 20, 2014 cancer stem cells linked to drug resistance date.
Herein, its pharmacokinetic views cancer cells acquire resistance to anticancer drugs. Mechanisms and insights into drug resistance in cancer. Overcoming multidrugresistant cancer with smart nanoparticles. Most drugs used to treat lung, breast and pancreatic cancers. Newly discovered molecules can kill multidrug resistant cancer cells by blocking cells defenses against cancer drugs, according to a new study. From a clinical point of view, it is thought that combining current therapies. Cancer stem cells linked to drug resistance by university of california san diego when lung cancer cells become drug resistant, tumor cells return as shown in brown. Clinically, drug resistance may develop either prior to drug therapy, or due to drug therapy. The engineered round nanoparticle is made of several layers.
Mechanically, we identify nrf2, which is a core transcription factor for lung cancer growth and drug resistance, as a target of sirt5. Unfortunately these very same abc efflux pumps afford protection to cancer stem cells in tumors, shielding them from the adverse effects of chemotherapy. More than 30 years ago, they discovered that in some cases, when patients go from being sensitive to resistant to treatment, their cancer cells start to overexpress abc transporters, he said. Resistance to anticancer drugs can be acquired by several mechanisms within neoplastic cells, defined as 1 alteration of drug targets, 2. Colonyforming assay cells were seeded at 100, 500, 2,000, and 10,000 cells 6cm culture plate.
Over the past 15 years, we have gained significant insight into one of the mechanisms responsible for this process. The arsenal that the cancer cell uses to accomplish this. In addition, cancer is characterized by extensive genetic and epigenetic alterations 2,3 and mutations in drug targets may also be responsible for increased drug resistance 4. Jul 29, 2014 furthermore, we find that sirt5 knockdown makes lung cancer cells more sensitive to drug cisdiamminedichloroplatinum cddp, 5fluorouracil 5fu or bleomycin treatment in vitro and in vivo. University of california, san diego health sciences summary. Hgf increases cisplatin resistance via downregulation of aif in lung cancer cells jintang chen1, chihyang huang2, yungyen chiang3, wenheng chen4, shiowher chiou2, chihyi chen5, and kuanchih chow4,5 1fengyuan hospital, fengyuan. In some cases, cancers can evolve resistance to multiple drugs, called multiple drug resistance there are two general causes of antineoplastic therapy failure. One approach showing promise in overcoming multidrug resistance in tumors is to.
788 857 1430 1224 306 624 521 159 151 760 213 1330 684 203 146 912 537 436 1196 1333 1276 360 545 786 1487 1038 918 752 72 1275 625 198 1283 1301 1180 1466 1484 149 58 1266